June 2013

FDA clears Rixubis to prevent bleeding in patients with hemophilia B ()
Markers of quality ()
EU makes strides (mostly) against heart disease ()
NICE clears Xarelto for pulmonary embolism ()
Japan approves Sapien XT valve ()
Downer diabetes trial: Weight loss, exercise fail to reduce cardiovascular risk ()
Drugs & money: Tailing top prescribers ()
‘Big 3’ performance measures predict overall quality ()
Saint Luke’s collaborative research shows strong link between liver disease, cardiovascular disease risk ()
Pay for performance, or pass it up? ()
European report tracks lead extractions from 46 countries ()
Cardiac MR helps ID low-risk CAD patients ()
Behind the scenes in Eliquis drama ()
Future of Echocardiography: Unlocking the Power of Volume Imaging ()
Use of laughing gas doesn’t increase cardiac risk ()
EHR gives clinic tools to monitor blood pressure ()
Taking heart disease to heart in your practice ()
High blood pressure among blacks and young adults is focus of $11 million stroke prevention project ()
NHLBI shifts from guideline producer to OEM ()
Academy of Nutrition and Dietetics collaborates on bipartisan Medicare bill to treat and reduce obesity ()
Payment rate propositions & perils ()
Tools help hospitals tackle atrial fibrillation ()
Saxagliptin misses efficacy mark in trial ()
AMA classifies obesity as disease ()
Fisher-Titus Medical Center and the Bellevue Hospital launch affiliation with the country’s No. 1 heart hospital, Cleveland Clinic ()
More evidence for pushing the ‘door-to-needle’ time ()
Bill Nye the Science Guy, still inspired and inspiring ()
Dare to differ: Team work, challenging vendors improves care, costs ()
Participatory & cozy ()
Medicare report takes aim at cardiac imaging services ()
Heart Rhythm Society visits Capitol Hill to gain support for important legislation impacting the field of electrophysiology ()
Lot of 2 mg warfarin tablets recalled ()
215 cardiovascular drugs under development ()
Cath lab alley-oop: 5 slam-dunk ways to cut cost, add value ()
FDA approves St. Jude’s safety-enhanced devices ()
Strategic partnering: Missteps & successes ()
Societies go to Washington ()
Standardization, structure counter healthcare chaos ()
Volumes drop but pay survives under value model ()
Textbook case, with no textbook ()
It’s rad: 1 in 6 PCIs in U.S. use radial approach ()
Alzheimer’s drug may lower risk of MI, death ()
Web-based program helps sites cut inappropriate imaging ()
Bioengineered vein: A first in U.S. ()
SCAI to EPA: Give more heed to occupational risks ()
FDA advisers call for easing Avandia restrictions ()
ACC launches program to reduce readmissions ()
From theory to action ()
Breaking-point news? Healthcare workers most stressed ()
Service lines: A Q&A with Suzette Jaskie ()
Peripheral balloon catheter released in U.S., Europe ()
Bariatric surgery improves risk factors but beware complications ()
AstraZeneca to buy lipid drug developer for $443M ()
Integrated practices dominate employment model ()
FDA briefing holds sharp criticisms about Avandia review ()
Closure devices, dabigatran stomp warfarin on costs ()
Avandia: The sequel ()
Service line symposium focuses on value ()